Remegen Funding: $100M Raised, Investors & Rounds

Remegen funding overview

Remegen is based in Yantai, Shandong Province, China. Remegen has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Remegen runs through 2020; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Lake Bleu Capital, Vivo Capital, Janchor Partners, OrbiMed, Hudson Bay Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Remegen at a glance

Total raised: $100M
Latest round date: April 2020
Headquarters: Yantai, Shandong Province, China
Notable investors: Lilly Asia Ventures, Lake Bleu Capital, Vivo Capital, Janchor Partners, OrbiMed, Hudson Bay Capital, Loyal Valley Capital, China Reform Conson Soochow Overseas Fund

Frequently asked about Remegen funding

How much has Remegen raised?: Remegen has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Remegen?: Lilly Asia Ventures, Lake Bleu Capital, Vivo Capital, Janchor Partners, OrbiMed, Hudson Bay Capital are named among the investors backing Remegen.
What was the latest Remegen funding round?: No round stage has been disclosed for Remegen.
Where is Remegen based?: Remegen is based in Yantai, Shandong Province, China.
When did Remegen last raise?: The last disclosed Remegen round closed in April 2020.

Round data for Remegen is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Yantai and backer lists below.

Remegen Funding: $100M Raised, Investors & Rounds

Remegen funding overview

Remegen at a glance

Frequently asked about Remegen funding

Companies related to Remegen (23)

Browse related funding lists (5)